Minerva Neurosciences

Prezzo Delle Azioni
6.33
Cambio Giornaliero
0.02 0.32%
Mensile
46.53%
Annuale
222.96%
Q1 Previsione
2.46




Ebit Cambiamento Data
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Adma Biologics USD 49.19M 7.26M 2025-09
ALKERMES USD 89.08M 3.9M 2025-09
Alterity Therapeutics Limited AUD -7.77M 2.99M 2023-06
AstraZeneca USD 2.97B 4.48B 2025-12
BioCryst Pharmaceuticals USD -4.51M 12.2M 2024-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 2.75B 1.35B 2024-12
Dynavax Technologies USD 21.27M 10.41M 2025-09
Eli Lilly USD 8.99B 1.57B 2025-12
Esperion Therapeutics USD -16.03M 11.51M 2024-09
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Grifols EUR 411.56M 15.51M 2025-09
Halozyme Therapeutics USD 217.92M 15.48M 2025-09
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
J&J USD 5.11B 2.3B 2025-12
Merck USD 6.24B 1.32B 2025-12
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Neurocrine Biosciences USD 239.3M 93.7M 2025-09
Novartis USD -9.19B 13.87B 2025-06
Novavax USD -134.02M 49.55M 2024-09
Pfizer USD 4.65B 71M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Takeda JPY 257.49B 568.56B 2025-12
Vanda Pharmaceuticals USD -10.28M 721K 2024-12


Minerva Neurosciences - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.